化学
取代基
芳香化酶
立体化学
对接(动物)
结构-活动关系
酶
IC50型
芳香化酶抑制剂
体外
生物化学
内科学
医学
癌症
护理部
乳腺癌
作者
Fernanda M.F. Roleira,Carla Varela,Cristina Amaral,Saúl C. Costa,Georgina Correia‐da‐Silva,Federica Moraca,Giosuè Costa,Stefano Alcaro,Natércia Teixeira,E. J. Tavares da Silva
标识
DOI:10.1021/acs.jmedchem.9b00157
摘要
C-6α and C-7α androstanes were studied to disclose which position among them is more convenient to functionalize to reach superior aromatase inhibition. In the first series, the study of C-6 versus C-7 methyl derivatives led to the very active compound 9 with IC50 of 0.06 μM and Ki = 0.025 μM (competitive inhibition). In the second series, the study of C-6 versus C-7 allyl derivatives led to the best aromatase inhibitor 13 of this work with IC50 of 0.055 μM and Ki = 0.0225 μM (irreversible inhibition). Beyond these findings, it was concluded that position C-6α is better to functionalize than C-7α, except when there is a C-4 substituent simultaneously. In addition, the methyl group was the best substituent, followed by the allyl group and next by the hydroxyl group. To rationalize the structure–activity relationship of the best inhibitor 13, molecular modeling studies were carried out.
科研通智能强力驱动
Strongly Powered by AbleSci AI